New EU Filings

Zanidatamab, Jazz and BeiGene’s investigational treatment for biliary tract cancer, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

New EU Filings
• Source: Shutterstock

This is a regularly updated searchable list of products that have been filed with the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) under the EU's centralized authorization procedure. The information is based on the EMA's monthly updated list of medicines under review at the agency, CHMP monthly meeting agendas, company press releases, and original research by the Pink Sheet. 

The EMA's latest monthly filings list comprised data extracted on 8 July. (Also see "Eleven New Drugs Filed...

More from Product Reviews

More from Pink Sheet